Other languages Genovis AB

Equities

GENO

SE0002485979

Delayed Nasdaq Stockholm Other stock markets 08:02:29 2024-05-17 EDT			5-day change	1st Jan Change
33.5 ^SEK	-2.90%		+11.30%	-35.58%

05-15	Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-14	Carthesian Therapeutics Terminates Genovis AB (Publ.) Licence Agreement	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024	05-15
Carthesian Therapeutics Terminates Genovis AB (Publ.) Licence Agreement	03-14
Genovis AB (publ.) Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-15
Genovis AB (publ.) Reports Earnings Results for the Full Year Ended December 31, 2023	02-15
Genovis to Get $1 Million Milestone Payment for Xork Development	02-13
Genovis AB (publ.) Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-15
Genovis AB (publ.) Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24
Genovis Launch Innovative Igm-Specific Protease with Wide-Ranging Applications in Life Science Markets	23-06-02
Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-16
ArcticZymes Technologies ASA and Genovis AB Announce Collaboration to Speed Up Penetration and Growth in the Chinese Market	23-05-03
Small Caps – Les derniers choix des stars de la gestion	23-02-17
Genovis AB (publ.) Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-15
Genovis AB (publ.) Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-15
Genovis AB (publ.) Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-15
Genovis AB (publ.) Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12
Genovis AB Enters Licensing and Supply Agreement with New Bioprocess Customer	22-08-10
Genovis AB Enters Service Agreement with Evitria Ag for Fast LC_MSlysis of Recombinant Antibodies	22-08-04
Genovis AB (Publ.) Announces Board Changes	22-05-12
Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27
Genovis AB (publ.) Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-02-08

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Genovis AB

Equities

GENO

SE0002485979

Other languages

Filters